InspireMD (NASDAQ: NSPR) is a commercial-stage medical device company dedicated to helping prevent stroke and save lives. The company empowers physicians and patients to choose carotid stenting without compromise by delivering smart design for stroke prevention through its proprietary MicroNet™ mesh technology. Uniquely engineered on the outside of the stent scaffold, the mesh is designed to reduce plaque prolapse and provide exceptional neurovascular protection during and after carotid procedures. InspireMD's flagship product, CGuard® Prime, is the only mesh-covered carotid stent, backed by unmatched clinical evidence and over 65,000 stents sold worldwide. The company is excited to bring the next generation of carotid stenting to physicians and patients across the United States.
Founded in 2005, InspireMD is headquartered in Miami, Florida, and employs 116 people. The company is publicly traded and has a strong focus on innovation and clinical evidence to support its products. InspireMD aims to revolutionize the field of carotid stenting by providing a safer and more effective solution for stroke prevention.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Public Company |
| Stock NSPR (Nasdaq) |
B2B professionals would contact <strong class="text-white font-semibold">InspireMD</strong> for its innovative and clinically proven carotid stenting solutions, which offer superior neurovascular protection and a strong commitment to stroke prevention.
Sales teams selling medical devices, particularly those focused on neurovascular protection, should reach out to <strong class="text-white font-semibold">InspireMD</strong>. Recruiters seeking roles in medical device innovation and clinical research should also consider this company.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with InspireMD